HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pietro Mastroeni Selected Research

Salmonella Infections (Salmonellosis)

1/2020Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?
10/2018Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
12/2016Immunology, epidemiology and mathematical modelling towards a better understanding of invasive non-typhoidal Salmonella disease and rational vaccination approaches.
2/2013Quantification of the effects of antibodies on the extra- and intracellular dynamics of Salmonella enterica.
5/2011Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells.
5/2006Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis.
8/2005Cytokine and chemokine responses associated with clearance of a primary Salmonella enterica serovar Typhimurium infection in the chicken and in protective immunity to rechallenge.
12/2004Cytokines in Salmonellosis.
4/2004Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues.
12/2003Characterization and development of T-Cell immune responses in B-cell-deficient (Igh-6(-/-)) mice with Salmonella enterica serovar Typhimurium infection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pietro Mastroeni Research Topics

Disease

24Infections
12/2021 - 06/2002
13Salmonella Infections (Salmonellosis)
01/2020 - 02/2002
3Inflammation (Inflammations)
10/2017 - 08/2005
3Granuloma
01/2017 - 10/2003
2Bacterial Infections (Bacterial Infection)
01/2020 - 01/2019
2Neoplasms (Cancer)
01/2017 - 12/2002
2Reinfection
06/2003 - 06/2002
1Porcine Reproductive and Respiratory Syndrome (PRRS)
12/2020
1Cutaneous Leishmaniasis
03/2020
1Peritonitis
10/2017
1Glioblastoma (Glioblastoma Multiforme)
10/2017
1Carcinoma (Carcinomatosis)
10/2017
1Persistent Infection
01/2017
1Necrosis
01/2017
1Typhoid Fever (Typhoid)
06/2011
1Critical Illness (Critically Ill)
02/2011
1Sepsis (Septicemia)
02/2011
1Brain Injuries (Brain Injury)
03/2007
1Ischemia
03/2007
1Coinfection
08/2005
1Shock
12/2004

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
12/2020 - 06/2003
7VaccinesIBA
01/2019 - 06/2003
5AntibodiesIBA
01/2020 - 06/2002
4Immunoglobulin G (IgG)IBA
01/2019 - 08/2004
4AntigensIBA
06/2011 - 12/2002
4NADPH Oxidases (NAD(P)H oxidase)IBA
09/2009 - 06/2002
3ChemokinesIBA
03/2007 - 04/2004
3NitrogenIBA
04/2004 - 06/2002
2Ampicillin (Omnipen)FDA LinkGeneric
01/2020 - 01/2017
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2017
2Ciprofloxacin (Cipro)FDA LinkGeneric
01/2020 - 01/2017
2Complement System Proteins (Complement)IBA
01/2019 - 02/2002
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
01/2017 - 04/2016
2Polysaccharides (Glycans)IBA
06/2011 - 05/2011
2Immunoglobulins (Immunoglobulin)IBA
05/2011 - 08/2004
2Toll-Like Receptor 4IBA
12/2009 - 09/2009
2Interferon-gamma (Interferon, gamma)IBA
08/2005 - 08/2004
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2005 - 06/2002
2Interleukin-10 (Interleukin 10)IBA
11/2004 - 08/2004
1phosphatidal ethanolaminesIBA
12/2021
1Phosphatidylcholines (Phosphatidylcholine)IBA
12/2021
1Pattern Recognition ReceptorsIBA
12/2020
1IsoenzymesIBA
03/2020
1IgG Receptors (Fc gamma RI)IBA
01/2019
1Complement C3 (C3 Complement)IBA
01/2019
1O Antigens (O Antigen)IBA
10/2018
1CRM197 (non-toxic variant of diphtheria toxin)IBA
10/2018
1GlycoconjugatesIBA
10/2018
1glyceryl methyl methacrylateIBA
10/2018
1Protein Isoforms (Isoforms)IBA
10/2017
1ChitinasesIBA
10/2017
1LatexIBA
10/2017
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
01/2017
1ProteomeIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
05/2011
1Pharmaceutical PreparationsIBA
04/2011
1GABA-A Receptors (GABA(A) Receptor)IBA
02/2011
1SolutionsIBA
02/2011
1Thiopental (Pentothal)FDA Link
02/2011
1Propofol (Diprivan)FDA LinkGeneric
02/2011
1Diazepam (Valium)FDA LinkGeneric
02/2011
1BenzodiazepinesIBA
02/2011
1Attenuated VaccinesIBA
08/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2006
1Conjugate VaccinesIBA
05/2006
1Immunoglobulin M (IgM)IBA
08/2005
1Immunoglobulin A (IgA)IBA
08/2005
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
08/2005
1transforming growth factor beta4IBA
08/2005
1Oxidoreductases (Dehydrogenase)IBA
03/2005
1Cytochromes b (Cytochrome b)IBA
03/2005
1LipopolysaccharidesIBA
12/2004
1Peptides (Polypeptides)IBA
09/2004
1DNA (Deoxyribonucleic Acid)IBA
08/2004
1Oxygen (Dioxygen)IBA
04/2004
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2003
1Salmonella VaccinesIBA
06/2003
1DNA VaccinesIBA
12/2002

Therapy/Procedure

2Therapeutics
01/2020 - 04/2011
1Critical Care (Surgical Intensive Care)
02/2011
1Immunotherapy
12/2002